Raloxifene, an oestrogen-receptor-β-targeted therapy, inhibits androgen-independent prostate cancer growth: results from preclinical studies and a pilot phase II clinical trial
Titel:
Raloxifene, an oestrogen-receptor-β-targeted therapy, inhibits androgen-independent prostate cancer growth: results from preclinical studies and a pilot phase II clinical trial
Auteur:
SHAZER, RONALD L. JAIN, ANJALI GALKIN, ANNA V. CINMAN, NADYA NGUYEN, KOO N. NATALE, RONALD B. GROSS, MITCHELL GREEN, LELAND BENDER, LEON I. HOLDEN, STUART KAPLAN, LESLIE AGUS, DAVID B.